Kidney International

• 

  Publication Venue For

  • Defining measures of kidney function in observational studies using routine health care data: methodological and reporting considerations..  103:53-69. 2023
  • Apolipoprotein-1 risk variants and associated kidney phenotypes in an adult HIV cohort in Nigeria..  100:146-154. 2021
  • Hypoxia signaling in renal pericytes-is it safe to activate?.  99:1267-1269. 2021
  • Scratching the itch: a new therapeutic target for dialysis-associated pruritus?.  97:444-447. 2020
  • Wyatt CM, Drueke TB. High-dose IV iron for anemia correction in chronic kidney disease. Kidney Int. 2019;95:727–730.  95:1518-1518. 2019
  • Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop..  94:1053-1068. 2018
  • Isotonic fluids for volume resuscitation: is it really 6 liters of one, half a dozen of another?.  93:1262-1264. 2018
  • Wyatt CM, Le Meur Y. REPRISE: tolvaptan in advanced polycystic kidney disease. Kidney Int. 2018;93:292–295.  93:1019-1019. 2018
  • REPRISE: tolvaptan in advanced polycystic kidney disease..  93:292-295. 2018
  • Increased body mass index is a risk factor for end-stage renal disease in the Chinese Singapore population..  92:979-987. 2017
  • How low can you go? Achieved blood pressure and cardiovascular outcomes..  92:536-539. 2017
  • In vitro generation of renal tubular epithelial cells from fibroblasts: implications for precision and regenerative medicine in nephrology..  91:265-267. 2017
  • Management of patients with diabetes and CKD: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference..  90:1175-1183. 2016
  • Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference..  90:1164-1174. 2016
  • HIF stabilization by prolyl hydroxylase inhibitors for the treatment of anemia in chronic kidney disease..  90:923-925. 2016
  • Timing is everything? Reconciling the results of recent trials in acute kidney injury..  90:718-721. 2016
  • Clinical trials of intensive versus less intensive control of hypertension: HOPE or HYPE?.  90:460-462. 2016
  • ISCHEMIA in chronic kidney disease: improving the representation of patients with chronic kidney disease in cardiovascular trials..  89:1178-1179. 2016
  • Higher hemoglobin levels and quality of life in patients with advanced chronic kidney disease: no longer a moving target?.  89:971-973. 2016
  • Good news and best wishes for 2016 to the global nephrology community from Kidney International..  89:2. 2016
  • Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar..  86:819-827. 2014
  • Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis.  86:1253-1259. 2014
  • A balanced view of calcium and phosphate homeostasis in chronic kidney disease.  83:789-791. 2013
  • The authors reply:.  82:489. 2012
  • Association between prehypertension and chronic kidney disease in the Japanese general population.  81:293-299. 2012
  • The authors reply:.  79:1259. 2011
  • Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function.  78:514-522. 2010
  • Response to Targeting hyperphosphatemia: Truth or dare.  77:257. 2010
  • The authors reply.  77:930. 2010
  • The authors reply.  77:648-649. 2010
  • The authors reply.  77:743-744. 2010
  • The bone and mineral disorder of children undergoing chronic peritoneal dialysis.  78:1295-1304. 2010
  • Response to Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression.  75:861-862. 2009
  • Collapsing glomerulopathy associated with inherited mitochondrial injury..  74:237-243. 2008
  • Renal metastases..  73:370. 2008
  • Response to 'Vitamin D levels and early mortality among incident hemodialysis patients'.  74:389. 2008
  • Clinical studies of hemodialysis access through formaldehyde-fixed arterial allografts..  72:1249-1254. 2007
  • Hypertension and albuminuria in chronic kidney disease mapped to a mouse chromosome 11 locus..  72:1226-1232. 2007
  • Vitamin D levels and early mortality among incident hemodialysis patients..  72:1004-1013. 2007
  • Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients..  71:454-461. 2007
  • Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'?.  70:1486-1494. 2006
  • CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney..  70:591-596. 2006
  • Vasopressin receptor antagonists..  69:2124-2130. 2006
  • The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients..  69:1662-1668. 2006
  • Safety of low-dose radiocontrast for interventional AV fistula salvage in stage 4 chronic kidney disease patients..  69:1444-1449. 2006
  • Combined expression of A1 and A20 achieves optimal protection of renal proximal tubular epithelial cells..  68:1520-1532. 2005
  • The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease..  67:265-271. 2005
  • Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy..  66:1686-1693. 2004
  • Regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF-A) expression in podocytes..  66:1471-1478. 2004
  • The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection..  66:1145-1152. 2004
  • Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study..  65:2380-2389. 2004
  • Definition of proteinuria among women with HIV infection..  65:1519. 2004
  • Taking HAART in HIVAN: will protease inhibitor sparing regimens alter renal outcome?.  65:1105-1106. 2004
  • Ethnic differences and determinants of proteinuria among South Asian subgroups in Pakistan..  64:1437-1444. 2003
  • Growth factor-mediated phosphorylation of proapoptotic BAD reduces tubule cell death in vitro and in vivo..  63:33-42. 2003
  • Long-term combined treatment with thiazide and potassium citrate in nephrolithiasis does not lead to hypokalemia or hypochloremic metabolic alkalosis..  63:240-247. 2003
  • Muscle atrophy in patients receiving hemodialysis: effects on muscle strength, muscle quality, and physical function..  63:291-297. 2003
  • Absence of donor MHC antigen expression ameliorates chronic kidney allograft rejection..  62:290-300. 2002
  • Monitoring changes in gene expression in renal ischemia-reperfusion in the rat..  61:1646-1654. 2002
  • Patients with Fabry disease on dialysis in the United States..  61:249-255. 2002
  • Predictors of proteinuria and renal failure among women with HIV infection..  61:195-202. 2002
  • Role of TGF-beta1 in renal parenchymal scarring following childhood urinary tract infection..  61:61-67. 2002
  • Deficiency of COX-1 causes natriuresis and enhanced sensitivity to ACE inhibition..  60:2324-2329. 2001
  • Comparison of transposed brachiobasilic fistulas to upper arm grafts and brachiocephalic fistulas..  60:1532-1539. 2001
  • Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography..  60:1490-1497. 2001
  • Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease..  60:1131-1140. 2001
  • Acute regulation of NHE3 by protein kinase A requires a multiprotein signal complex..  60:450-454. 2001
  • Hemodialysis arteriovenous access: detection of stenosis and response to treatment by vascular access blood flow..  59:358-362. 2001
  • Endothelin antagonism and contrast nephropathy..  58:2239. 2000
  • HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy..  58:173-181. 2000
  • Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies..  58:137-143. 2000
  • A role for leukotrienes in cyclosporine nephrotoxicity..  57:2586-2593. 2000
  • Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients with end-stage renal disease..  57:2129-2135. 2000
  • Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism..  57:1675-1680. 2000
  • Preventing bone loss after renal transplantation with bisphosphonates: we can... but should we?.  57:735-737. 2000
  • A trial of thyroxine in acute renal failure..  57:293-298. 2000
  • Endothelin antagonism and contrast nephropathy - Reply from the authors.  58:2239-2239. 2000
  • Renal function in the at1A receptor knockout mouse during normal and volume-expanded conditions.  56:1846-1854. 1999
  • Spectrum of disease in familial focal and segmentai glomerulosclerosis.  56:1855-1862. 1999
  • Renal function in the AT1A receptor knockout mouse during normal and volume-expanded conditions..  56:1855-1862. 1999
  • Spectrum of disease in familial focal and segmental glomerulosclerosis..  56:1863-1871. 1999
  • Gene targeting: applications in transplantation research..  56:18-27. 1999
  • Aluminum is a weak agonist for the calcium-sensing receptor..  55:1750-1758. 1999
  • Chronic rejection of mouse kidney allografts..  55:1935-1944. 1999
  • Clinical and genetic heterogeneity in familial focal segmental glomerulosclerosis. International Collaborative Group for the Study of Familial Focal Segmental Glomerulosclerosis..  55:1241-1246. 1999
  • Fas on renal parenchymal cells does not promote autoimmune nephritis in MRL mice..  55:841-851. 1999
  • HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection..  55:1036-1040. 1999
  • Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cells..  55:454-464. 1999
  • Potential role for G-protein coupled receptors in HIV-associated nephropathy..  54:2243-2244. 1998
  • Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients..  54:1684-1689. 1998
  • Molecular cloning of KS, a novel rat gene expressed exclusively in the kidney..  54:1444-1454. 1998
  • Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy. Collaborative Study Group..  54:193-202. 1998
  • Treatment of infected tunneled venous access hemodialysis catheters with guidewire exchange..  53:1792-1794. 1998
  • Angiotensinogen gene null-mutant mice lack homeostatic regulation of glomerular filtration and tubular reabsorption..  53:617-625. 1998
  • Immortalized rat proximal tubule cells produce membrane bound and soluble megalin..  53:358-366. 1998
  • Synergistic effect of dexamethasone and isoproterenol on the expression of angiotensinogen in immortalized rat proximal tubular cells..  53:287-295. 1998
  • A role for T cell co-stimulation in ischemic acute renal failure?.  52:1706-1707. 1997
  • Systemic autoimmune nephritogenic components induce CSF-1 and TNF-alpha in MRL kidneys..  52:934-941. 1997
  • Renal TGF-beta in HIV-associated kidney diseases..  51:1568-1577. 1997
  • Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study..  50:1734-1746. 1996
  • Lupus autoantibodies interact directly with distinct glomerular and vascular cell surface antigens..  49:1214-1221. 1996
  • Risk factors for renal allograft loss in patients with systemic lupus erythematosus..  49:512-517. 1996
  • Transplant approach establishes that kidneys are responsible for serum CSF-1 but require a stimulus in MRL-lpr mice..  49:67-74. 1996
  • NF-kappa B and transcriptional control of renal epithelial-inducible nitric oxide synthase..  48:674-682. 1995
  • Role of platelet activating factor in kidney transplant rejection in the rat..  48:337-343. 1995
  • Insulin-like growth factor-I gene expression in the tibial epiphyseal growth plate of growth hormone-treated uremic rats..  47:1374-1382. 1995
  • Transport of phosphorothioate oligonucleotides in kidney: implications for molecular therapy..  47:1462-1469. 1995
  • Developmental expression of renal angiotensin II receptor genes in the mouse..  47:140-147. 1995
  • Desensitization of angiotensin receptor function..  46:1499-1501. 1994
  • Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD..  45:1710-1721. 1994
  • Correction of central venous stenoses: use of angioplasty and vascular Wallstents..  45:1177-1181. 1994
  • Expression of clusterin in human renal diseases..  45:828-835. 1994
  • Analysis and isolation of renal tubular cells by flow cytometry..  42:997-1005. 1992
  • Continuous arteriovenous hemodialysis: effect of dialyzer geometry..  42:448-451. 1992
  • Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites..  41:1690-1700. 1992
  • Fistula dysfunction: effect on rapid hemodialysis..  41:1292-1296. 1992
  • Thromboxane receptor blockade reduces renal injury in murine lupus nephritis..  41:973-982. 1992
  • Effects of thromboxane synthase inhibition with CGS 13080 in human cyclosporine nephrotoxicity..  41:199-205. 1992
  • Racial differences in the incidence and progression of renal diseases..  40:815-822. 1991
  • Enhanced renal leukotriene production in murine lupus: role of lipoxygenase metabolites..  39:95-102. 1991
  • Identification of calcium-calmodulin multifunctional protein kinase II in rabbit kidney..  38:63-66. 1990
  • Study of rat renal brush border membrane vesicles by flow cytometry..  38:5-11. 1990
  • FRACTIONATION OF SOLUBILIZED RABBIT RENAL BRUSH-BORDER MEMBRANES (BBM) BY ANION-EXCHANGE CHROMATOGRAPHY DISSOCIATES THE ACTIVITY OF THE RECONSTITUTED NA+-H+ EXCHANGER FROM ITS REGULATION BY CAMP DEPENDENT PROTEIN-KINASE (PKA).  37:234-234. 1990
  • RECOMBINANT HUMAN 5-HT1A RECEPTOR IN HELA-CELLS STIMULATES NA+/K+ ATPASE ACTIVITY VIA A CALCIUM-DEPENDENT MECHANISM.  37:567-567. 1990
  • THE CLONED HUMAN 5-HT1A RECEPTOR EXPRESSED IN HELA-CELLS STIMULATES SODIUM-DEPENDENT PHOSPHATE-TRANSPORT (SDPT) VIA PROTEIN KINASE-C (PKC).  37:202-202. 1990
  • THE THROMBOXANE (TX) SYNTHETASE INHIBITOR CGS-13080 IMPROVES RENAL-ALLOGRAFT FUNCTION IN PATIENTS TAKING CYCLOSPORINE (CYA).  37:604-604. 1990
  • Prevention of hemodialysis fistula thrombosis. Early detection of venous stenoses..  36:707-711. 1989
  • Regulation of the renal Na+-H+ exchanger by protein phosphorylation..  36:519-525. 1989
  • Post-transplant hypertension in the rat: effects of captopril and native nephrectomy..  36:35-40. 1989
  • CAPTOPRIL TEST VERSUS CAPTOPRIL-STIMULATED PLASMA-RENIN AS SCREENING-TESTS FOR RENOVASCULAR HYPERTENSION.  35:335-335. 1989
  • CO-RECONSTITUTION OF TRYPSINIZED SOLUBILIZED BRUSH-BORDER MEMBRANE-PROTEINS WITH SMALL MOLECULAR-WEIGHT PEPTIDES RESTORES THE INHIBITORY EFFECT OF PKA ON THE NA+-H+ EXCHANGER.  35:166-166. 1989
  • Chronic thromboxane inhibition preserves function of rejecting rat renal allografts..  35:24-30. 1989
  • INVITRO INTERLEUKIN -2 (IL2) EFFECT ON SPONTANEOUS IMMUNOGLOBIN-G (IGG) PRODUCTION IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE).  35:375-375. 1989
  • THE GENOMIC CLONE G-21 ENCODES THE HUMAN 5-HT1A RECEPTOR.  35:163-163. 1989
  • Oral calcitriol and calcium: efficient therapy for uremic hyperparathyroidism..  34:840-844. 1988
  • Hemodialysis-associated subclavian vein stenosis..  33:1156-1159. 1988
  • INVITRO B-CELL INTERLEUKIN-2 (IL-2) RECEPTOR EXPRESSION IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE).  33:334-334. 1988
  • TRYPSIN STIMULATION OF RENAL NA+-H+ EXCHANGER.  33:408-408. 1988
  • Renal and circulatory mechanisms in congestive heart failure..  31:1402-1415. 1987
  • ASSOCIATION OF THE REGULATORY SUBUNIT OF CYCLIC-AMP DEPENDENT PROTEIN-KINASE WITH THE RABBIT APICAL MEMBRANES.  31:181-181. 1987
  • ENRICHMENT OF ALPHA2-ADRENERGIC RECEPTORS OF RABBIT PROXIMAL TUBULE BASOLATERAL MEMBRANES (BLM).  31:178-178. 1987
  • RECONSTITUTION OF CAMP PROTEIN-KINASE REGULATED RENAL NA+-H+ EXCHANGER.  31:186-186. 1987
  • SUBUNIT INTERACTIONS - DISCUSSION.  32:S51-S55. 1987
  • Bilateral native nephrectomy improves renal isograft function in rats..  30:20-26. 1986
  • RANDOMIZED PLACEBO-CONTROLLED TRIAL OF ORAL POTASSIUM IN MILD ESSENTIAL-HYPERTENSION.  29:259-259. 1986
  • Reactivation of latent murine cytomegalovirus from kidney..  28:922-925. 1985
  • Feasibility and benefits of exercise training in patients on maintenance dialysis..  25:958-963. 1984
  • Structural and functional response of toad urinary bladder to LiCl..  24:719-730. 1983
  • Practicing nephrology with a computerized medical record..  24:446-454. 1983
  • Effects of two models of hypercalcemia on renal acid base metabolism..  21:613-620. 1982
  • The Fanconi syndrome and mechanisms of tubular transport dysfunction..  20:705-716. 1981
  • Urine and serum lactic dehydrogenase, lactic dehydrogenase isoenzymes, and alkaline phosphatase in the nephrotic syndrome..  19:710-715. 1981
  • Cisplatin-induced changes in sodium, chloride, and urea transport by the frog skin..  19:8-14. 1981
  • RECURRENT GLOMERULONEPHRITIS-(GN) IN TRANSPLANTS.  19:265-265. 1981
  • Inhibitor of marrow thymidine incorporation from sera of patients with uremia..  18:715-724. 1980
  • Effect of vasopressin and serosal hypertonicity on toad urinary bladder..  16:695-703. 1979
  • Vasopressin (VP) induced changed in the epithelial surface of toad urinary bladder.  15:448-449. 1979
  • Cystine transport in isolated rat renal tubules.  14:739. 1978
  • Effect of colchicine and cytochalasin B (CB) on vasopressin (VP)- and cyclic adenosine monophosphate (cAMP)-induced changes in the epithelial surface of toad urinary bladder.  14:767. 1978
  • PHOSPHATURIA DURING ACUTE HYPERCAPNIA (HC).  8:404-404. 1975
  • Serological evidence of cross infection in a dialysis unit hepatitis-B epidemic..  6:118-121. 1974
  • Compensatory renal growth after unilateral ureteral obstruction..  4:22-27. 1973
  • Erratum: Long-term combined treatment with thiazide and potassium citrate in nephrolithiasis does not lead to hypokalemia or hypochloremic metabolic alkalosis (Kidney International (2003) 63 (240-247)).  64:390. 2003
  • HISTAMINE-H1 RECEPTORS STIMULATE SODIUM-DEPENDENT PHOSPHATE-UPTAKE VIA A PERTUSSIS TOXIN-INSENSITIVE G-PROTEIN AND PROTEIN KINASE-C IN HELA-CELLS 1990
  • PROTEIN KINASE-A (PKA) AND PROTEIN KINASE-C (PKC) HAVE OPPOSITE EFFECTS ON PHOSPHATE-TRANSPORT IN HELA-CELLS 1990
  • COMPARISON OF CYCLIC-AMP PATHWAYS IN HUMAN AND OPOSSUM PROXIMAL RENAL-CELLS 1989
  • GLOMERULAR ATRIAL NATRIURETIC FACTOR (ANF) RECEPTORS IN PRIMARY GLOMERULOPATHIES - STUDIES ON HUMAN RENAL BIOPSIES 1989
  • HUMAN PROXIMAL RENAL-CELLS IN CULTURE - HORMONAL EFFECTS ON PHOSPHATE-TRANSPORT 1989
  • INHIBITION OF PTH-STIMULATED ADENYLATE-CYCLASE IN PROXIMAL TUBULE CELLS - EVIDENCE FOR AMPLIFICATION OF CYCLIC-AMP 1989
  • USE OF THE RENAL BIOPSY TO PROBE THE PATHOPHYSIOLOGY OF HUMAN RENAL-DISEASE - GLOMERULAR BINDING OF ATRIAL-NATRIURETIC-PEPTIDE (ANP) 1987
  • ASSAY FOR URINE AND PLASMA OXALATE BY GC/MS ISOTOPE-DILUTION 1986
  • RELIABLE MEASUREMENT OF URINE AND PLASMA OXALATE BY GC/MS 1985